GLENMARK
Invest with MTF
Invest Now
Invest in Glenmark Pharmaceuticals with 3.41X leverage
Performance
- Low
- ₹2,026
- High
- ₹2,048
- 52 Week Low
- ₹1,276
- 52 Week High
- ₹2,285
- Open Price₹2,031
- Previous Close₹2,030
- Volume360,664
Investment Returns
- Over 1 Month + 4.57%
- Over 3 Month + 3.93%
- Over 6 Month + 18.93%
- Over 1 Year + 28.02%
Smart Investing Starts Here Start SIP with Glenmark Pharmaceuticals for Steady Growth!
Glenmark Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 56.9
- PEG Ratio
- 0.3
- Market Cap Cr
- 57,434
- P/B Ratio
- 6
- Average True Range
- 39.07
- EPS
- 89.11
- Dividend Yield
- 0.2
- MACD Signal
- 27.88
- RSI
- 63.6
- MFI
- 74.59
Glenmark Pharmaceuticals Financials
Glenmark Pharmaceuticals Technicals
EMA & SMA
Current Price
₹2,035.20
+
5.4
(0.27%)
- Bearish Moving Average 0
- Bullish Moving Average 16
- 20 Day
- ₹1,986.28
- 50 Day
- ₹1,951.66
- 100 Day
- ₹1,918.34
- 200 Day
- ₹1,820.62
Resistance and Support
2036.43
- R3 2,069.87
- R2 2,059.13
- R1 2,047.17
- S1 2,024.47
- S2 2,013.73
- S3 2,001.77
Glenmark Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
Glenmark Pharmaceuticals F&O
About Glenmark Pharmaceuticals
- NSE Symbol
- GLENMARK
- BSE Symbol
- 532296
- Chairman & Managing Director
- Mr. Glenn Saldanha
- ISIN
- INE935A01035
Similar Stocks to Glenmark Pharmaceuticals
Glenmark Pharmaceuticals FAQs
Glenmark Pharmaceuticals share price is ₹2,035 As on 31 December, 2025 | 22:17
The Market Cap of Glenmark Pharmaceuticals is ₹57433.5 Cr As on 31 December, 2025 | 22:17
The P/E ratio of Glenmark Pharmaceuticals is 56.9 As on 31 December, 2025 | 22:17
The PB ratio of Glenmark Pharmaceuticals is 6 As on 31 December, 2025 | 22:17
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.